SpineEx filed with the U.S. Securities and Exchange Commission to raise up to US $17MM in an initial public offering to support commercialization of spinal fusion devices. In previous Series A and B financings, the company has raised gross proceeds of $3.3MM to date.
The company has developed the Sagittae® expandable and adjustable cage for lateral lumbar fusion. FDA 510(k) submission occurred in 2Q18, and clearance is expected by year-end.
If cleared, Sagittae would be accompanied by the Scorpio Retractor with disposable accessories and the Herculaes' Sterilization Container (the latter of which is already approved for sale in China).